PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 3/26
Copy link
Facebook
Email
Notes
More

Market Analysis and Trades for 3/26

PharmD_KS's avatar
PharmD_KS
Mar 25, 2025
∙ Paid
15

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 3/26
Copy link
Facebook
Email
Notes
More
1
Share

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so there is no reason to subscribe to both

Note: There will be a price increase on the Discord at the end of the week. As always this will NOT impact anyone already in the Discord (future subscribers only). There will be no change in pricing for the newsletter at this time.

The PharmD_KS Indicator script has now been updated and automatically converts the ES levels to either SPY or SPX per your preference. The link can be found here PharmD_KS Indicator Script V6

The weekly post and for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. Link to Market Analysis for The Week Ahead

Today was all about the major high time frame spot on ES, 5811-5813. Sellers made multiple attempts to crack it, repeatedly failing, and ultimately having to cover into the close. We traded 1dte ES 5850 calls off the last hold which as of the time of this writing have traded $9+ from the $3.85 entry at 3:13 EDT (we have taken profits). From last night’s plan:

This was an opportunistic trade which can be managed overnight. For now, I remain cautious on rips, but constructive on dips.

Paid Content Below

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More